ECM
PFE icon

Endex Capital Management’s Pfizer PFE Stock Holding History

Endex Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$2.27M Hold
78,024
– – 2.11% 4
2013
Q3 		$2.13M Hold
78,024
– – 2.18% 5
2013
Q2 		$2.07M Buy
+78,024
New +$2.16M 2.21% 4

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Endex Capital Management's PFE Position: Q4 2013 in Review

Endex Capital Management held its Pfizer (PFE) position steady in Q4 2013 at 78,024 shares worth $2.27M. The position accounts for 2.11% of the portfolio, ranked #4.

Endex Capital Management first reported a position in PFE in Q2 2013 and has held it in 3 quarters since. 1,737 funds tracked by Wall St. Rank hold PFE as of Q4 2013.

  • Endex Capital Management held 78,024 shares of Pfizer worth $2.27M as of Q4 2013.
  • Endex Capital Management left its Pfizer share count unchanged in Q4 2013.
  • Pfizer made up 2.11% of Endex Capital Management's portfolio in Q4 2013, its #4 holding.
  • Endex Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 3 quarters since.
  • 1,737 funds tracked by Wall St. Rank held Pfizer as of Q4 2013.

Based on Endex Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.